Medigus Ltd (MDGS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Medigus Ltd (MDGS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6398
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medigus Ltd (Medigus) is a medical device company that develops minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The company’s muse system enables endoscopists to treat gastroesophageal reflux disease (GERD) by performing fundoplication procedures through the mouth. Its muse system addresses the unmet need in long-term treatment for GERD. Medigus’ platform includes various rigid, semi-flexible and flexible video endoscopes, SRS endoscope, micro cameras, endoscopy suites, staplers and ultrasound sensors. The company also offers micro cameras for medical endoscopy, remote visual inspection, industrial endoscopy, non-destructive testing and machine vision applications. It markets products across Israel and the US. Medigus is headquartered in Omer, Israel.

Medigus Ltd (MDGS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medigus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medigus Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Medigus Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medigus Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Medigus Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Medigus Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Medigus Enters into Co-Development Agreement with AM Surgical 10
Medigus Enters Into Distribution Agreement With China National Pharma For SRS II Systems 11
Equity Offering 12
Medigus Raises USD10 Million in Public Offering of Units 12
Medigus Prices USD1.6 Million in Private Placement of Shares 13
Medigus Prices Public Offering of Units for USD7.5 Million 14
Medigus Raises USD7.1 Million in Public Offering of Shares 15
Medigus Raises USD3 Million in Equity Financing 16
Medigus Raises USD11 Million in Private Placement of Shares and Warrants 17
Medigus Raises USD5.6 Million in Private Placement of Shares and Warrants 19
Medigus Completes Public Offering Of Shares For US$7 Million 20
Medigus Completes Private Placement Of Shares For US$8 Million 21
Medigus Ltd – Key Competitors 22
Medigus Ltd – Key Employees 23
Medigus Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 30, 2018: Medigus announces second quarter 2018 financial results 25
Jun 11, 2018: Medigus Reports First Quarter 2018 Financial Results 26
Mar 22, 2018: Medigus Ltd Announces Fourth Quarter and Fiscal Year 2017 Financial Results 27
Nov 24, 2017: Medigus Announces Third Quarter 2017 Financial Results 28
Sep 18, 2017: Medigus Announces Second Quarter 2017 Financial Results 29
May 30, 2017: Medigus Announces First Quarter 2017 Financial Results 30
Legal and Regulatory 31
Jan 16, 2017: Medigus Receives Nasdaq Letter Regarding Bid Price Compliance 31
Product News 32
May 15, 2017: Medigus Announces Japanese and European Patents for micro ScoutCam Microvisual Technology 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Medigus Ltd, Medical Equipment, Key Facts, 2017 2
Medigus Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Medigus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medigus Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Medigus Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medigus Ltd, Deals By Market, 2012 to YTD 2018 8
Medigus Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Medigus Enters into Co-Development Agreement with AM Surgical 10
Medigus Enters Into Distribution Agreement With China National Pharma For SRS II Systems 11
Medigus Raises USD10 Million in Public Offering of Units 12
Medigus Prices USD1.6 Million in Private Placement of Shares 13
Medigus Prices Public Offering of Units for USD7.5 Million 14
Medigus Raises USD7.1 Million in Public Offering of Shares 15
Medigus Raises USD3 Million in Equity Financing 16
Medigus Raises USD11 Million in Private Placement of Shares and Warrants 17
Medigus Raises USD5.6 Million in Private Placement of Shares and Warrants 19
Medigus Completes Public Offering Of Shares For US$7 Million 20
Medigus Completes Private Placement Of Shares For US$8 Million 21
Medigus Ltd, Key Competitors 22
Medigus Ltd, Key Employees 23
Medigus Ltd, Other Locations 24
Medigus Ltd, Subsidiaries 24

List of Figures
Medigus Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Medigus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Medigus Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Medigus Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Medigus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medigus Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Medigus Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medigus Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Medigus Ltd (MDGS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • InterOil Corporation (IOC)-石油・ガス分野:企業M&A・提携分析
    Summary InterOil Corporation (InterOil) is an independent oil and gas company that carries out acquisition, exploration and development of oil and gas assets. It principally focuses on liquefied natural gas (LNG) projects in Papua New Guinea (PNG). It has several exploration licenses in the prospect …
  • Pathway Genomics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pathway Genomics Corp (Pathway Genomics) is a healthcare laboratory that offers genetic testing services. Its tests comprise liquid biopsy cancer intercept, true hereditary cancer genetic tests, DNA insight general health and wellness genetic tests, DNA insight pharmacogenomics tests, and ca …
  • Circassia Group Plc (CIR):企業の財務・戦略的SWOT分析
    Circassia Group Plc (CIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Juniper Networks Inc (JNPR):企業の財務・戦略的SWOT分析
    Juniper Networks Inc (JNPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Contango Oil & Gas Co (MCF):石油・ガス:M&Aディール及び事業提携情報
    Summary Contango Oil & Gas Co (Contango) is an oil and natural gas company that explores, exploits, develops, produces and acquires crude oil and natural gas properties. The company provides operation for both offshore and onshore producing assets. Its offshore operations comprise Vermilion 170 plat …
  • Toppan Forms Co Ltd
    Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Dragon Oil Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Dragon Oil Plc (Dragon Oil), a subsidiary of Emirates National Oil Company Ltd, is an independent oil and gas company that carries out acquisition, exploration, and development of hydrocarbon resources. It focuses on properties in offshore Turkmenistan and exploration assets in Iraq, Algeria …
  • Hutchison 3G UK Limited:戦略・SWOT・企業財務分析
    Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report Summary Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • EndoGastric Solutions Inc:医療機器:M&Aディール及び事業提携情報
    Summary EndoGastric Solutions Inc (EGS), formerly EsophyX Inc, is a medical device company that manufactures and markets gastroenterology and surgical products for the treatment of gastroesophageal reflux disease (GERD). The company’s products comprise esophyX device and Serosa-Fuse fasteners. Its t …
  • Methode Electronics Inc (MEI):企業の財務・戦略的SWOT分析
    Summary Methode Electronics Inc (Methode) is technology company. The company offers products such as automotive and transportation, high voltage switchgear, high-speed copper transceivers and modules, bus bars, custom user interface, dabir surfaces, discrete and analog switching, emi receptacles, fo …
  • Telecom Plus plc (TEP):企業の財務・戦略的SWOT分析
    Telecom Plus plc (TEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Toyota Tsusho Corporation (8015)-エネルギー分野:企業M&A・提携分析
    Summary Toyota Tsusho Corporation (Toyota Tsusho) is a diversified general trading and project management company. The company trades steel, aluminum, machinery, electronics, energy, chemicals, and other consumer products. It also provides passenger cars, buses, motorcycles, trucks, used vehicles, e …
  • ILF Consulting Engineers:企業の戦略・SWOT・財務情報
    ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report Summary ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kala Pharmaceuticals Inc (KALA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kala Pharmaceuticals Inc (Kala Pharmaceuticals) is a clinical stage pharmaceutical company that offers nanoparticle-based treatments for ocular diseases affecting both front and back of the eye. The company’s lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase III …
  • Amcor Ltd:戦略・SWOT・企業財務分析
    Amcor Ltd - Strategy, SWOT and Corporate Finance Report Summary Amcor Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Interpace Biosciences Inc (IDXG):企業の製品パイプライン分析
    Summary Interpace Biosciences Inc (Interpace Biosciences) formerly Interpace Diagnostics Group Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathf …
  • DURECT Corp (DRRX)-製薬・医療分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • The Maryland Technology Development Corp:企業のM&A・事業提携・投資動向
    The Maryland Technology Development Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Maryland Technology Development Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • Bandera Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Bandera Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Aerostar S.A.:企業の戦略・SWOT・財務分析
    Aerostar S.A. - Strategy, SWOT and Corporate Finance Report Summary Aerostar S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆